134 related articles for article (PubMed ID: 2453881)
1. Class 1 (unique) tumor antigens of human melanoma: identification of unique and common epitopes on a 90-kDa glycoprotein.
Real FX; Furukawa KS; Mattes MJ; Gusik SA; Cordon-Cardo C; Oettgen HF; Old LJ; Lloyd KO
Proc Natl Acad Sci U S A; 1988 Jun; 85(11):3965-9. PubMed ID: 2453881
[TBL] [Abstract][Full Text] [Related]
2. Class 1 (unique) tumor antigens of human melanoma: partial purification and characterization of the FD antigen and analysis of a mouse polyclonal antiserum.
Mattes MJ; Real FX; Furukawa K; Old LJ; Lloyd KO
Cancer Res; 1987 Dec; 47(24 Pt 1):6614-9. PubMed ID: 2445475
[TBL] [Abstract][Full Text] [Related]
3. A unique antigenic epitope of human melanoma is carried on the common melanoma glycoprotein gp95/p97.
Furukawa KS; Furukawa K; Real FX; Old LJ; Lloyd KO
J Exp Med; 1989 Feb; 169(2):585-90. PubMed ID: 2463331
[TBL] [Abstract][Full Text] [Related]
4. Class 1 (unique) tumor antigens of human melanoma. Identification of a 90,000 dalton cell surface glycoprotein by autologous antibody.
Real FX; Mattes MJ; Houghton AN; Oettgen HF; Lloyd KO; Old LJ
J Exp Med; 1984 Oct; 160(4):1219-33. PubMed ID: 6237165
[TBL] [Abstract][Full Text] [Related]
5. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
[TBL] [Abstract][Full Text] [Related]
6. A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels.
Shockley TR; Lin K; Sung C; Nagy JA; Tompkins RG; Dedrick RL; Dvorak HF; Yarmush ML
Cancer Res; 1992 Jan; 52(2):357-66. PubMed ID: 1728407
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens.
Saxton RE; Mann BD; Morton DL; Burk MW
Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138
[TBL] [Abstract][Full Text] [Related]
8. ME491 melanoma-associated glycoprotein family: antigenic identity of ME491, NKI/C-3, neuroglandular antigen (NGA), and CD63 proteins.
Demetrick DJ; Herlyn D; Tretiak M; Creasey D; Clevers H; Donoso LA; Vennegoor CJ; Dixon WT; Jerry LM
J Natl Cancer Inst; 1992 Mar; 84(6):422-9. PubMed ID: 1371549
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody recognizing human melanoma-carcinoma cross-reacting oncofetal antigen epitopically associated with carcinoembryonic antigen.
Liao SK; Kwong PC; Clarke BJ; Dent PB; Ryan ED; Khosravi MJ; Laferte S; Krantz MJ
J Natl Cancer Inst; 1985 May; 74(5):1047-58. PubMed ID: 2582173
[TBL] [Abstract][Full Text] [Related]
10. Identification of a widely distributed 90-kDa glycoprotein that is homologous to the Hermes-1 human lymphocyte homing receptor.
Pals ST; Hogervorst F; Keizer GD; Thepen T; Horst E; Figdor CC
J Immunol; 1989 Aug; 143(3):851-7. PubMed ID: 2663988
[TBL] [Abstract][Full Text] [Related]
11. Detection of phenotypic differences on human malignant melanoma lines and their variant sublines with monoclonal antibodies.
Brüggen J; Sorg C
Cancer Immunol Immunother; 1983; 15(3):200-5. PubMed ID: 6555061
[TBL] [Abstract][Full Text] [Related]
12. Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies.
Dippold WG; Lloyd KO; Li LT; Ikeda H; Oettgen HF; Old LJ
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6114-8. PubMed ID: 6934537
[TBL] [Abstract][Full Text] [Related]
13. Serological and biochemical analyses of monoclonal antibodies to human melanoma-associated antigens.
Harper JR; Bumol TF; Reisfeld RA
Hybridoma; 1982; 1(4):423-32. PubMed ID: 6208137
[TBL] [Abstract][Full Text] [Related]
14. Common human melanoma-associated antigen(s) detected by monoclonal antibodies.
Carrel S; Accolla RS; Carmagnola AL; Mach JP
Cancer Res; 1980 Jul; 40(7):2523-8. PubMed ID: 6155995
[TBL] [Abstract][Full Text] [Related]
15. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
16. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
[TBL] [Abstract][Full Text] [Related]
17. Characterization of monoclonal antibody 155.8 and partial characterization of its proteoglycan antigen on human melanoma cells.
Harper JR; Bumol TF; Reisfeld RA
J Immunol; 1984 Apr; 132(4):2096-104. PubMed ID: 6199423
[TBL] [Abstract][Full Text] [Related]
18. Workshop on monoclonal antibodies to human melanoma-associated antigens: findings of the Seattle group.
Hellström I; Brown JP; Hellström KE
Hybridoma; 1982; 1(4):399-402. PubMed ID: 6208136
[TBL] [Abstract][Full Text] [Related]
19. Antimelanoma hybridoma antibodies against partially purified melanoma antigen.
Medrano L; Cesarini JP; Daveau M; Phillips J; Salazar G; Fontaine M; Phillips T; Viza D; Prunieras M
Eur J Cancer Clin Oncol; 1983 Feb; 19(2):153-61. PubMed ID: 6337853
[TBL] [Abstract][Full Text] [Related]
20. Production and characterization of monoclonal antibody to a melanoma specific glycoprotein.
Morgan AC; Galloway DR; Reisfeld RA
Hybridoma; 1981; 1(1):27-36. PubMed ID: 6208119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
